<DOC>
	<DOC>NCT00781521</DOC>
	<brief_summary>This was a pilot study to determine the safety and effectiveness of a twice daily, seven-day dosing regimen in acute, pediatric, otitis media in children with tympanostomy tubes. The currently approved regimen is twice daily for 10 days.</brief_summary>
	<brief_title>Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<criteria>Male or female 6 months of age to &lt;12 years of age weight = or &gt;4.5 kg Patent tympanostomy tube(s) in the affected ear(s) Purulent or mucopurulent otorrhea of recent onset of presumed bacterial origin Nonbacterial otic infection Known or suspected hypersensitivity to ofloxacin Cystic fibrosis HIV infection Neutropenia Receiving immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>